Melvin Toh

Evaluator
DISC Type : csd

Vice President & Chief Scientific Officer at CK Life Sciences

Hong Kong SAR

Overview

Melvin Toh serves as the Vice President & Chief Scientific Officer at CK Life Sciences, guiding technology and product development. With over 25 years of experience in Asia and the US, including a prior role as a Director at Pfizer, he specializes in pharmaceuticals and oncology. He earned his MBBS from the National University of Singapore.

He is leading CK Life Sciences development of a novel AI-empowered cancer vaccine platform, aiming to accelerate research and improve the discovery of new therapies.

Personality Overview

Hard To Convince

Thorough Evaluator

Fast But Analytical

They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical  They focus on the results, but can still be quite procedural and analytical about how to get there They are not very likely to become strong advocates of your product or service

Topics They Care About

AI in Drug Discovery
He is leading a collaboration to develop an AI-powered platform for cancer vaccine R&D and has spoken on AI's role in medical diagnostics.
Oncology Development
He previously directed oncology development at Pfizer and now focuses on Asia-centric tumor biology and building a therapeutic cancer vaccine program at CK Life Sciences.
Medical Diagnostics
His interests include developing new medical diagnostics, particularly prognostic tests for cancer management and leveraging machine-learning for early detection.

Media Appearances

Melvin Toh – CK Life Sciences International (Holdings) Inc. Speaker Profile. Featured in Informa Connect

See Now

Interview with Melvin Toh, Executive Director, Vice President & Chief Scientific Officer, CK Life Sciences (PDF). Featured in PharmaBoardroom

See Now

Work History

11-2018
Vice President & Chief Scientific Officer at CK Life Sciences
10-2008 - 11-2018
VP, Pharmaceutical Development at CK Life Sciences
1-2008 - 10-2008
VP, Clinical & Regulatory Affairs at CK Life Sciences
1-2005 - 1-2008
Director, Clinical Pharmacology, Oncology Development, San Diego, USA at Pfizer
7-2002 - 12-2004
Medical Director, Pfizer Clinical Research Unit, Singapore at Pfizer

Education

MBBS from National University of Singapore
MSc from University of London

More Information

Social Presence :

Prographics :

Exp : 28 Location : Hong Kong SAR Job Level : Leadership Designation : Vice President & Chief Scientific Officer at CK Life Sciences
URL has been copied!

Insights For Selling To Melvin

During A Call Or A Meeting

DO's

  • Help them weigh the risks by sharing objective proof points instead of anecdotes and examples
  • Keep a professional, business-like approach; especially if you tend to get informal quickly
  • Help them see both - the ‘big picture’ impact and the ROI of the investment

DONT's

  • Don’t focus on relationship, focus purely on the merit of your product
  • Avoid inviting them for any social interactions until you have built some rapport with them
  • Avoid self-deprecating references or general informality, it could decrease their trust in you

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Melvin is

  • ROI matters the most to them, followed by process and finally proof of results
  • Will you ever get a clear answer from Melvin

  • They might hesitate a little, but will go ahead and say no when necessary (or asked)

Insights For Deal Planning

    How fast (or slow) will Melvin move?

  • They are unlikely to move very fast, especially when it comes to new products or services
  • Can Melvin take some risk or not?

  • They have relatively low risk-appetite and are not very likely to go for something unproven and risky

You And Melvin

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.